Glucose regulation via electrical stimulation of nerves innervating the liver

• US 9,872,985 B2
• Filed: 03/03/2016
• Issued: 01/23/2018
• Est. Priority Date: 03/03/2015
• Status: Active Grant

• Current Assignee: Georgia Tech Research Corporation (University System of Georgia)
• Original Assignee: Georgia Tech Research Corporation (University System of Georgia)
• Inventors: Butera, Robert, Patel, Yogi Anil
• Primary Examiner(s): Alter, Alyssa M
• Application Number:
  US15/060,132
• Publication Number:
  US 20160256683A1
• Time in Patent Office: 691 Days
• CPC Class Codes: A61N 1/0551 Spinal or peripheral nerve electrodes
• CPC Class Codes: A61N 1/36053 adapted for vagal stimulation A61N1/36114 takes precedence
• CPC Class Codes: A61N 1/36085 Eating disorders or obesity
• CPC Class Codes: A61N 1/36139 with automatic adjustment
• CPC Class Codes: A61N 1/36157 Current A61N1/3616 takes precedence
• CPC Class Codes: A61N 1/36171 Frequency

Abstract

An example method for causing a perturbation of blood glucose level in a subject is described herein. The method can include selectively inhibiting neural activity of at least one of a hepatic branch of the subject'"'"'s vagus nerve or the subject'"'"'s greater splanchnic nerve using electrical stimulation having a frequency greater than about 5 kHz. The selective inhibition of neural activity causes the subject'"'"'s blood glucose level to increase or decrease as compared to a baseline level.

Claims

1. A method for causing a perturbation of blood glucose level in a subject, comprising:

selectively inhibiting neural activity of at least one of a hepatic branch of the subject'"'"'s vagus nerve or the subject'"'"'s greater splanchnic nerve using electrical stimulation having a frequency about 50 kHz or greater, wherein the selective inhibition of neural activity causes the subject'"'"'s blood glucose level to increase or decrease as compared to a baseline level.

2. The method of claim 1, further comprising selectively exciting neural activity of at least one of the hepatic branch of the subject'"'"'s vagus nerve or the subject'"'"'s greater splanchnic nerve using electrical stimulation, wherein the selective excitation and inhibition of neural activity causes the subject'"'"'s blood glucose level to increase or decrease as compared to the baseline level.

3. The method of claim 2, wherein neural activity of the hepatic branch of the subject'"'"'s vagus nerve is selectively excited using electrical stimulation.

4. The method of claim 1, wherein neural activity of the subject'"'"'s greater splanchnic nerve is selectively inhibited using electrical stimulation having a frequency about 50 kHz or greater.

5. The method of claim 1, wherein the electrical stimulation delivers a current with an amplitude from about 100 μ

A to about 10 mA.

6. The method of claim 2, wherein neural activity of at least one of the hepatic branch of the subject'"'"'s vagus nerve or the subject'"'"'s greater splanchnic nerve is selectively excited using electrical stimulation having a frequency from about 1 Hz to about 200 Hz.

7. The method of claim 6, wherein the electrical stimulation delivers a current with an amplitude from about 50 μ

A to about 50 mA.

8. The method of claim 1, further comprising:

administering a substance to the subject;

measuring the subject'"'"'s blood glucose level at each of a plurality of time intervals;

adjusting one or more stimulation parameters based on the subject'"'"'s measured blood glucose level; and

altering a glucose load associated with the substance through the selective excitation or inhibition of neural activity.

9. The method of claim 8, wherein the substance is administered to the subject orally or through injection.

10. The method of claim 1, wherein the selective excitation or inhibition of neural activity further causes a change in level of a metabolite.

11. The method of claim 1, further comprising providing a first electrode at a portion of the hepatic branch of the subject'"'"'s vagus nerve and a second electrode at a portion of the subject'"'"'s greater splanchnic nerve.

12. The method of claim 11, wherein the first electrode is provided between the subject'"'"'s liver and the subject'"'"'s vagal trunk.

13. The method of claim 11, wherein the second electrode is provided between the subject'"'"'s suprarenal ganglia and celiac ganglia.

14. The method of claim 11, wherein at least one of the first electrode or the second electrode is a monopolar, bipolar, or tripolar electrode.

15. The method of claim 1, further comprising monitoring the subject'"'"'s blood glucose level.

16. The method of claim 15, further comprising controlling the selective excitation or inhibition of neural activity based on the subject'"'"'s blood glucose level.

17. The method of claim 1, further comprising controlling the selective excitation or inhibition of neural activity based on user input.

18. The method of claim 1, further comprising controlling the selective excitation or inhibition of neural activity based on a predetermined time schedule.

19. The method of claim 1, wherein neural activity of at least one of the hepatic branch of the subject'"'"'s vagus nerve or the subject'"'"'s greater splanchnic nerve is selectively inhibited using electrical stimulation having a frequency from 50 kHz to 100 kHz.

20. A device for causing a perturbation of blood glucose level in a subject, comprising:

a first electrode configured to attach to a portion of a hepatic branch of the subject'"'"'s vagus nerve;

a second electrode configured to attach to a portion of the subject'"'"'s greater splanchnic nerve;

a stimulus generator operably coupled with the first electrode and the second electrode, the stimulus generator being configured to provide stimulus signals to at least one of the first electrode and the second electrode; and

a control unit operably coupled with the stimulus generator, the control unit comprising a processor and memory operably coupled to the processor, wherein the control unit is configured to control the stimulus generator to;

provide a first stimulus signal configured to selectively excite neural activity of at least one of the hepatic branch of the subject'"'"'s vagus nerve or the subject'"'"'s greater splanchnic nerve; and

provide a second stimulus signal having a frequency about 50 kHz or greater and configured to selectively inhibit neural activity of at least one of the hepatic branch of the subject'"'"'s vagus nerve or the subject'"'"'s greater splanchnic nerve, wherein the selective excitation and inhibition of neural activity causes the subject'"'"'s blood glucose level to increase or decrease as compared to a baseline level.